Moreover, the AAV-NF-α1/CPE-treated 3 × Tg-AD mice demonstrate suppression of APP expression through decreasing the transcription factors Sp1 and Hsf1, which bind the promoter of APP to regulate its expression. This evidence concerns the gene SP1 and Alzheimer disease.